Industry news that matters to you.  Learn more

Philips and Mount Sinai Health System Collaborate to Advance Clinical Research Through New Digital Pathology Database and Analytics

Royal Philips (NYSE:PHG, AEX:PHIA) recently announced a joint development agreement with the Mount Sinai Health System, an integrated health system in New York, to create a state-of-the-art digital image repository of patient tissue samples and innovative data analytics to pursue the discovery of new tissue-based tests and unlock pathology data. The collaboration aims to advance clinical research and ultimately enable better care for complex diseases, including cancer.

Philips and UC Irvine Partner to Develop Standards for Breast Cancer Screening

Royal Philips (NYSE: PHG, AEX: PHIA) recently announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time. The study will rely on Philips’ MicroDose SI mammography spectral imaging technology. Designed to address the industry’s growing concern about the lower diagnostic accuracy of mammography for high density breasts, MicroDose SI joins Philips’ suite of diagnostic imaging solutions designed to enhance imaging quality for confident diagnostics at a low dose.

Critical Diagnostics Widens its Footprint in The Asia Pacific Region For its Cardiac Biomarker ST2

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, today announced that it continues to expand its presence in the Asia Pacific region with the addition of two distribution partners.

Biocartis Collaborates with Philips and Wellcome Trust in Oncology Diagnostics

Biocartis recently announced that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full IP rights, with access to IP created during this scope of this collaboration.

Philips and Definiens to Jointly Develop Digital Pathology System

Royal Philips Electronics and Definiens have signed an agreement to jointly develop a digital pathology system. The system will support the clinical diagnosis of several types of cancer, starting with breast cancer.